These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25171061)

  • 1. TIMP-3 expression associates with malignant behaviors and predicts favorable survival in HCC.
    Gu X; Fu M; Ding Y; Ni H; Zhang W; Zhu Y; Tang X; Xiong L; Li J; Qiu L; Xu J; Zhu J
    PLoS One; 2014; 9(8):e106161. PubMed ID: 25171061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-5692a promotes the invasion and metastasis of hepatocellular carcinoma via MMP9.
    Sun SJ; Wang N; Sun ZW; Chen J; Cui HW
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4869-4878. PubMed ID: 30070322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and inhibitory role of TIMP-3 in hepatocellular carcinoma.
    Shen B; Jiang Y; Chen YR; Zheng HC; Zeng W; Li YY; Yin A; Nie Y
    Oncol Rep; 2016 Jul; 36(1):494-502. PubMed ID: 27222429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of a high activity of matrix metalloproteinase-9 to low levels of tissue inhibitors of metalloproteinase-1 and -3 in human hepatitis B-viral hepatoma cells.
    Kim JR; Kim CH
    Int J Biochem Cell Biol; 2004 Nov; 36(11):2293-306. PubMed ID: 15313474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Expression of Neuropilin-1 Associates with Unfavorable Clinicopathological Features in Hepatocellular Carcinoma.
    Zhang Y; Liu P; Jiang Y; Dou X; Yan J; Ma C; Fan Q; Wang W; Su F; Tang H; Su X
    Pathol Oncol Res; 2016 Apr; 22(2):367-75. PubMed ID: 26563279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular distribution of transcripts for tissue inhibitor of metalloproteinases 1 and 2 in human hepatocellular carcinomas.
    Nakatsukasa H; Ashida K; Higashi T; Ohguchi S; Tsuboi S; Hino N; Nouso K; Urabe Y; Kinugasa N; Yoshida K; Uematsu S; Ishizaki M; Kobayashi Y; Tsuji T
    Hepatology; 1996 Jul; 24(1):82-8. PubMed ID: 8707287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of MAGE-A9 correlates with unfavorable survival in hepatocellular carcinoma.
    Gu X; Fu M; Ge Z; Zhan F; Ding Y; Ni H; Zhang W; Zhu Y; Tang X; Xiong L; Li J; Qiu L; Mao Y; Zhu J
    Sci Rep; 2014 Oct; 4():6625. PubMed ID: 25315972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TIMP-3 gene transfection suppresses invasive and metastatic capacity of human hepatocarcinoma cell line HCC-7721.
    Zhang H; Wang YS; Han G; Shi Y
    Hepatobiliary Pancreat Dis Int; 2007 Oct; 6(5):487-91. PubMed ID: 17897911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of chitinase 3-like 1: a novel prognostic predictor for hepatocellular carcinoma.
    Pan JJ; Ge YS; Xu GL; Jia WD; Liu WF; Li JS; Liu WB
    J Cancer Res Clin Oncol; 2013 Jun; 139(6):1043-54. PubMed ID: 23525579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
    Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
    Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
    Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
    Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
    Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
    BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role and mechanism of circ-PRKCI in hepatocellular carcinoma.
    Qi SX; Sun H; Liu H; Yu J; Jiang ZY; Yan P
    World J Gastroenterol; 2019 Apr; 25(16):1964-1974. PubMed ID: 31086464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-7 downregulates the oncogene VDAC1 to influence hepatocellular carcinoma proliferation and metastasis.
    Wang F; Qiang Y; Zhu L; Jiang Y; Wang Y; Shao X; Yin L; Chen J; Chen Z
    Tumour Biol; 2016 Aug; 37(8):10235-46. PubMed ID: 26831666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of thymosin beta 10 predicts poor prognosis for hepatocellular carcinoma after hepatectomy.
    Wang H; Jiang S; Zhang Y; Pan K; Xia J; Chen M
    World J Surg Oncol; 2014 Jul; 12():226. PubMed ID: 25037578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular carcinoma.
    Giannelli G; Bergamini C; Marinosci F; Fransvea E; Quaranta M; Lupo L; Schiraldi O; Antonaci S
    Int J Cancer; 2002 Feb; 97(4):425-31. PubMed ID: 11802202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between TIMP-3 expression and promoter methylation of TIMP-3 gene in hepatocellular carcinoma].
    Lü GL; Wen JM; Xu JM; Zhang M; Xu RB; Tian BL
    Zhonghua Bing Li Xue Za Zhi; 2003 Jun; 32(3):230-3. PubMed ID: 12882688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of SOX-1 expression in human hepatocelluar cancer.
    Lou J; Zhang K; Chen J; Gao Y; Wang R; Chen LB
    Int J Clin Exp Pathol; 2015; 8(5):5411-8. PubMed ID: 26191244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.